SCHEMBL21780342

SCHEMBL21780342

NCC1(NC=O)COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2841634 0.78
SCHEMBL2842008 0.74 USP2 (0.30)
SCHEMBL8124456 0.73 USP2 (0.33)
SCHEMBL14690787 0.69
SCHEMBL15213164 0.64
SCHEMBL18924686 0.59
Bromide SCHEMBL1394599 0.55 EPHX1 (0.35)
SCHEMBL10626682 0.55
SCHEMBL1485749 0.55
Hydrochloric Acid SCHEMBL7962177 0.55 EPHX1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3097098-B1 PROCESS FOR THE PREPARATION OF N-[(3-AMINOOXETAN-3-YL)METHYL]-2-(1,1-DIOXO-3,5-DIHYDRO-1,4-BENZOTHIAZEPIN-4-YL)-6-METHYL-QUINAZOLIN-4-AMINE HOFFMANN LA ROCHE (CH) 2020-03-04 EP disclosed
EP-3248969-B1 PROCESS FOR THE PREPARATION OF N-[3-(AMINOMETHYL)OXETAN-3-YL]CARBAMATE INTERMEDIATES HOFFMANN LA ROCHE (CH) 2020-03-04 EP disclosed